Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long‐term treatment of predominantly moderate acne with or without concomitant medication – results from the non‐interventional cohort study ELANG

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. S4, 2015-06 ,pp. : 15-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do tutorials on application method enhance adapalene–benzoyl peroxide combination gel tolerability in the treatment of acne?

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 11, 2015-11 ,pp. : 1058-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 6, 2015-06 ,pp. : 557-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of Life under Capecitabine (Xeloda®) in Patients with Metastatic Breast Cancer: Data from a German Non-Interventional Surveillance Study

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-11 ,pp. : 748-755

Karger

Access to resources Recommend Favorite

Capecitabine in the Routine Treatment of Advanced Breast Cancer: Results from a Non-Interventional Observational Study in 876 Patients

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 631-636

Karger

Access to resources Recommend Favorite